REGENXBIO Inc.

RGNX

—

Advanced chart & tools →

REGENXBIO Inc.RGNX

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-3.76

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$170.44M

Net income

$-193.88M

Net margin

-113.8%

Gross margin

—

Dividends & financials

REGENXBIO Inc. (RGNX) reported revenue of $170.44M and net income of $-193.88M, or $-3.76 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.